Cetuximab, sold under the brand name Erbitux, is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic...
26 KB (2,542 words) - 19:54, 20 March 2024
drug cetuximab. They discovered that these individuals had IgE antibodies in their blood that were specifically targeted to the portion of cetuximab which...
34 KB (3,737 words) - 16:50, 14 July 2024
infiltrative disorders such as sarcoidosis. Cetuximab is the first-line therapy for Ménétrier disease. Cetuximab is a monoclonal antibody against epidermal...
10 KB (1,083 words) - 02:45, 22 June 2024
Panitumumab (section Panitumumab vs. cetuximab)
the labels of two anti-EGFR monoclonal antibody drugs (panitumumab and cetuximab) indicated for the treatment of metastatic colorectal cancer to include...
16 KB (1,421 words) - 15:40, 14 July 2024
Allergic Facial nerve palsy Anti-cancer treatments such as erlotinib, cetuximab, and panitumumab, which block the function of EGFR (the epidermal growth...
3 KB (220 words) - 15:43, 11 May 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
121 KB (13,799 words) - 06:42, 1 July 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
31 KB (3,413 words) - 23:30, 21 June 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
150 KB (15,741 words) - 10:52, 27 June 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
68 KB (5,993 words) - 00:47, 13 July 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
92 KB (8,667 words) - 03:16, 15 July 2024
At ImClone, Waksal led the company to develop the cancer drug Erbitux (cetuximab). During the course of its review process with the Food and Drug Administration...
17 KB (1,396 words) - 10:45, 31 March 2024
of a drug depends on the genotype of a patient. For example, Erbitux (cetuximab) increases the survival rate of colorectal cancer patients if they carry...
33 KB (3,391 words) - 17:06, 12 July 2024
disorders, such as Anorexia nervosa Pregnancy Prostaglandin analogues Cetuximab Bimatoprost, Latanoprost Phenytoin Minoxidil Ciclosporin Topiramate Streptomycin...
4 KB (421 words) - 18:23, 28 March 2024
June 2024, the US FDA granted accelerated approval to adagrasib plus cetuximab for adults with KRAS G12C-mutated locally advanced or metastatic colorectal...
11 KB (688 words) - 07:28, 25 June 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
42 KB (3,935 words) - 04:01, 30 April 2024
receptor inhibitors, of which the three FDA approved ones are aflibercept, cetuximab and panitumumab. The primary difference in the approach to low stage rectal...
145 KB (15,791 words) - 05:59, 14 July 2024
Examples of radiosensitizing drugs include cisplatin, nimorazole, and cetuximab. The impact of radiotherapy varies between different types of cancer and...
113 KB (13,531 words) - 22:40, 29 June 2024
non-primate mammals, alpha-gal is also found in cat dander and in the drug cetuximab. Allergic reactions to alpha-gal usually occur 3–6 hours after consuming...
18 KB (2,188 words) - 20:01, 3 May 2024
(lomustine) Droxia/Hydrea (hydroxycarbamide) Empliciti (Elotuzumab) Erbitux (cetuximab) Etopophos (etoposide) Ixempra (ixabepilone) Lysodren (mitotane) Megace...
92 KB (7,420 words) - 07:46, 19 June 2024
FOLFIRI is often[citation needed] combined with bevacizumab, aflibercept, cetuximab or panitumumab to improve efficacy and response rate. In the short term...
4 KB (411 words) - 21:05, 6 May 2024
advantage at three years was noted when cetuximab was given concurrently with radiation (bioradiation). Cetuximab trials were completed prior to knowledge...
233 KB (24,397 words) - 05:09, 24 June 2024
was predictive of a very poor response to panitumumab (Vectibix) and cetuximab (Erbitux) therapy in colorectal cancer. As of 2008, the most reliable...
45 KB (5,079 words) - 06:39, 25 June 2024
currently used conventional antibodies like trastuzumab (targeting HER2/neu), cetuximab and panitumumab (both targeting the EGF receptor), using the BiTE approach...
9 KB (1,471 words) - 05:15, 1 July 2024
MAbs approved by the FDA for cancer include: Alemtuzumab Bevacizumab Cetuximab Dostarlimab Gemtuzumab ozogamicin Ipilimumab Nivolumab Ofatumumab Panitumumab...
47 KB (4,802 words) - 02:10, 28 June 2024
targeted therapies used in head and neck cancers include cetuximab, bevacizumab, and erlotinib. Cetuximab is used for treating people with advanced-stage cancer...
104 KB (11,622 words) - 11:21, 21 June 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
23 KB (1,755 words) - 04:41, 3 July 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
25 KB (2,085 words) - 03:15, 6 July 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
17 KB (1,489 words) - 05:47, 7 April 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
34 KB (3,021 words) - 04:42, 11 July 2024
Icotinib Lapatinib Neratinib Osimertinib Vandetanib WHI-P 154 Antibodies: Cetuximab Depatuxizumab Depatuxizumab mafodotin Futuximab Imgatuzumab Matuzumab...
13 KB (1,179 words) - 04:00, 15 July 2024